DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Omniscan (Gadodiamide) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (56)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Omniscan (Gadodiamide) disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 56   Next >>

Possible Omniscan side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-20

Patient: male, weighing 93.0 kg (204.6 pounds)

Reactions: Pain in Extremity, Motor Dysfunction, Nephrogenic Systemic Fibrosis, Arthralgia, Joint Swelling, Sensory Disturbance, Musculoskeletal Stiffness, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan



Possible Omniscan side effects in 54 year old male

Reported by a lawyer from United States on 2012-07-17

Patient: 54 year old male

Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Muscle Rigidity, Neuropathic Ulcer, Erythema, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Arthralgia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-12-12
    End date: 2000-12-12

Omniscan
    Indication: Arthralgia

Omniscan
    Indication: Sepsis

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-11-29

Other drugs received by patient: Lansoprazole; Atacand HCT; Vitamin E; Verapamil HCL; Minoxidil; Misoprostol; Lorazepam; Amiodarone HCL; Humulin R; Phoslo; Vitamin D; Epoetin Alfa; Cytotec; Calcium Acetate; Cefazolin Sodium



Possible Omniscan side effects in male

Reported by a individual with unspecified qualification from Denmark on 2012-07-06

Patient: male, weighing 93.0 kg (204.6 pounds)

Reactions: Impaired Work Ability, Motor Dysfunction, Nephrogenic Systemic Fibrosis, Arthralgia, Skin Discolouration, Joint Swelling, Musculoskeletal Stiffness, Skin Atrophy, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan



Possible Omniscan side effects in male

Reported by a individual with unspecified qualification from Denmark on 2012-07-06

Patient: male, weighing 87.0 kg (191.4 pounds)

Reactions: Pain in Extremity, Motor Dysfunction, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Headache, Activities of Daily Living Impaired, Cerebral Calcification, Carpal Tunnel Syndrome, Gait Disturbance, Open Wound, Mobility Decreased, Neuralgia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Indication: Renal Transplant
    Start date: 2004-08-31
    End date: 2004-08-31

Omniscan
    Start date: 2006-06-08
    End date: 2006-06-08



Possible Omniscan side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: 54 year old male

Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-11-29

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-12-12
    End date: 2000-12-12

Optimark

Magnevist

Omniscan

Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec



Possible Omniscan side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-21

Patient: 68 year old female, weighing 45.6 kg (100.3 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2002-12-28
    End date: 2002-12-28

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-02-08
    End date: 2005-02-08

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-05-27
    End date: 2006-05-27

Other drugs received by patient: Calcium Carbonate; Ferrous Citrate; Primperan TAB; Metoprolol Tartrate; Potassium Gluconate TAB; Selbex; Clonazepam; Bepricor



Possible Omniscan side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-21

Patient: 57 year old female, weighing 44.0 kg (96.8 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 15 ml (daily dose), , intravenous
    Indication: Peripheral Vascular Disorder
    Start date: 2006-10-03
    End date: 2006-10-03

Magnevist
    Dosage: 20 ml (daily dose), once, intravenous
    Indication: Acoustic Neuroma
    Start date: 2004-09-30
    End date: 2004-09-30

Omniscan
    Indication: Acoustic Neuroma
    Start date: 2006-10-01
    End date: 2006-10-01

Omniscan
    Dosage: 15 ml (daily dose), , intravenous
    Start date: 2007-10-02
    End date: 2007-10-02

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 15 ml (daily dose), , intravenous
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-11-01
    End date: 2005-11-01

Other drugs received by patient: Famotidine; Losartan Potassium; Diazepam; Calcium Carbonate; Alfarol; Vitamin B12; Carvedilol; Aspirin; Adenosine; Warfarin Sodium; Mucodyne



Possible Omniscan side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: 54 year old male

Reactions: Abasia, Pain, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-12-12
    End date: 2000-12-12

Optimark

Omniscan



Possible Omniscan side effects in female

Reported by a physician from Norway on 2012-06-11

Patient: female, weighing 40.0 kg (88.0 pounds)

Reactions: Pain in Extremity, Headache, Eye Pain, Paraesthesia, Haemoglobin Decreased, Visual Impairment, Dizziness, Serum Ferritin Decreased, Eyelid Ptosis, Skin Atrophy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan



Possible Omniscan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-11

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Prohance
    Indication: Renal Mass
    Start date: 2003-07-03
    End date: 2003-07-03

Omniscan
    Indication: Liver Disorder
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Neck Pain
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-07-13
    End date: 2004-07-13

Prohance
    Indication: Renal Scan
    Start date: 2003-07-03
    End date: 2003-07-03

Omniscan
    Indication: Osteomyelitis
    Start date: 2004-07-13
    End date: 2004-07-13

Contrast Media
    Indication: Decubitus Ulcer
    Start date: 2005-04-14
    End date: 2005-04-14

Magnevist

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Contrast Media
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Multihance
    Indication: Diagnostic Procedure

Optimark

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Other drugs received by patient: Plavix; Iron; Clonidine; Calcitriol; Proamatine; Epogen; Renvela; Cozaar; Calcium Carbonate; Metoprolol Tartrate; Sensipar; Rena-Vite; Phoslo; Hectorol; Renagel; Amlodipine; Fosrenol; Lisinopril; Foltx



Possible Omniscan side effects in 14 year old male

Reported by a physician from Japan on 2012-06-08

Patient: 14 year old male, weighing 48.0 kg (105.6 pounds)

Reactions: Pruritus, Hyperkeratosis, Hyperthermia, Joint Contracture, Pyrexia, Scleroderma, Erythema, Oedema Peripheral, White Blood Cell Count Increased, Pain in Extremity, Rash Papular, Muscle Contracture, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Collagen Disorder, Hypoproteinaemia, Grip Strength Decreased, Inflammation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 10 ml (daily dose), once, intravenous
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-12-28
    End date: 2006-12-28

Omniscan
    Dosage: 10 ml (daily dose), once, intravenous
    Start date: 2007-01-12
    End date: 2007-01-12

Omniscan
    Dosage: 10 ml (daily dose), once, intravenous
    Indication: Glaucoma
    Start date: 2006-09-04
    End date: 2006-09-04

Magnevist
    Dosage: 10 ml (daily dose), once, intravenous
    Start date: 2004-12-17
    End date: 2004-12-17

Magnevist
    Dosage: 10 ml (daily dose), once, intravenous
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-24
    End date: 2004-07-24

Other drugs received by patient: Calcium Carbonate; Calcium Carbonate; Dexamethasone; Allopurinol; Amlodipine; Ferrous Citrate



Possible Omniscan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Prohance
    Dosage: 17 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-07-03
    End date: 2003-07-03

Magnevist

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Optimark

Multihance

Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx



Possible Omniscan side effects in 52 year old female

Reported by a consumer/non-health professional from United States on 2012-05-04

Patient: 52 year old female, weighing 59.0 kg (129.7 pounds)

Reactions: Soft Tissue Disorder, Joint Contracture, Abasia, Pain, Skin Hyperpigmentation, Muscle Fibrosis, Joint Stiffness, Myosclerosis, Calcification of Muscle, Skin Discolouration, Impaired Self-Care, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Unevaluable Event, Extremity Contracture, Skin Disorder, Skin Hypopigmentation, Nephrogenic Systemic Fibrosis, Skin Induration, Stress, Amnesia, Skin Plaque, Anxiety, Dysphonia, Skin Fibrosis, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1998-06-01
    End date: 1998-06-01

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Thoracic
    Start date: 1999-05-14
    End date: 1999-05-14

Omniscan
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2001-07-20
    End date: 2001-07-20

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Thoracic
    Start date: 2003-09-09
    End date: 2003-09-09

Omniscan
    Dosage: 0.15 mmol/kg
    Start date: 2000-04-18
    End date: 2000-04-18

Omniscan
    Dosage: 30 ml, once
    Indication: Venogram
    Start date: 2000-10-19
    End date: 2000-10-19

Omniscan
    Dosage: 0.1 mmol/kg, unk
    Start date: 2003-10-20
    End date: 2003-10-20

Omniscan
    Dosage: 40 ml, once
    Start date: 2001-10-16
    End date: 2001-10-16

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1998-06-01
    End date: 1998-06-01

Magnevist
    Dosage: unk
    Start date: 2003-09-25
    End date: 2003-09-25

Omniscan
    Dosage: 50 ml, once
    Start date: 2003-09-30
    End date: 2003-09-30

Magnevist
    Indication: Angiogram

Omniscan
    Dosage: daily dose 40 ml
    Start date: 2002-11-01
    End date: 2002-11-01

Omniscan
    Dosage: 0.2mmol/kg
    Start date: 2003-09-27
    End date: 2003-09-27

Omniscan
    Dosage: 0.1mmol/kg
    Start date: 2003-10-03
    End date: 2003-10-03

Other drugs received by patient: Simvastatin; Coumadin; Avapro; Maxidex; Claforan; Omnipaque 140; Metoprolol Tartrate; Enalapril Maleate; Chlorothiazide; Furosemide; Moduretic 5-50; Cozaar; Lasix; Magnesium Oxide; Potassium Chloride; Benadryl; Nifedipine; Sevelamer; Potassium Chloride; Spironolactone; Epogen; Iron Supplement; Omnipaque 140; Clonidine; Flonase



Possible Omniscan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02

Patient: male, weighing 77.6 kg (170.6 pounds)

Reactions: Femoral Arterial Stenosis, Headache, Cyst, Pulmonary Granuloma, Tunnel Vision, Malaise, Nodule, Temperature Intolerance, Back Pain, Actinic Keratosis, Prostate Cancer, Coronary Artery Disease, Nephrogenic Systemic Fibrosis, Helicobacter Infection, Neurodermatitis, Hypoaesthesia, Stress, Activities of Daily Living Impaired, Ventricular Tachycardia, Ear Pain, Fall, Poor Quality Sleep, Fatigue, Basal Cell Carcinoma, Dizziness, Acute Myocardial Infarction, Vomiting, Supraventricular Extrasystoles, Nausea, Squamous Cell Carcinoma, Bundle Branch Block Left, Rash, Ascites, Carotid Artery Stenosis, Meniscus Lesion, Diarrhoea, Atrioventricular Block, Gait Disturbance, Arthritis, Asthenia, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-12-15
    End date: 2005-12-15

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-09-23

Other drugs received by patient: Simvastatin; Diovan; Renal Softgel; Minoxidil



Possible Omniscan side effects in female

Reported by a physician from United States on 2012-05-01

Patient: female

Reactions: Abdominal Pain, Orthostatic Hypotension, Pulmonary Embolism, Osteomyelitis, Headache, Ingrowing Nail, Staphylococcal Bacteraemia, Arteriosclerosis, Back Pain, Localised Infection, Pneumonia, Anaemia, Hypotension, Helicobacter Infection, Nephrogenic Systemic Fibrosis, Nail Hypertrophy, Osteopenia, Osteosclerosis, Iliac Artery Stenosis, Dehydration, Impaired Gastric Emptying, Spinal Column Stenosis, Pain, Fall, Hypoacusis, Skin Ulcer, Intervertebral Discitis, Chest Pain, Arteriovenous Fistula Thrombosis, Blood Pressure Increased, Vomiting, Nausea, Syncope, Diarrhoea, Sepsis, Retroperitoneal Lymphadenopathy, Spinal Osteoarthritis, Deep Vein Thrombosis, Infectious Peritonitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-03
    End date: 2006-03-03

Multihance
    Dosage: 15 ml, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2008-07-30
    End date: 2008-07-30

Gadolinium
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2010-01-01
    End date: 2010-01-01

Optimark
    Indication: Angiogram

Omniscan
    Dosage: 40 ml, single
    Indication: Angiogram
    Start date: 2007-02-06
    End date: 2007-02-06

Multihance
    Dosage: 17 ml, single
    Start date: 2009-11-19
    End date: 2009-11-19



Possible Omniscan side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30

Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)

Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Depression, Mobility Decreased, Scar

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-04-25
    End date: 2006-04-25

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 20 ml, once
    Start date: 2006-05-21
    End date: 2006-05-21

Other drugs received by patient: Nephrocaps; Losartan Potassium; Aldactone; Insulin; Albumin (Human); Cardizem; Zemplar; Procardia XL; Aranesp; Catapres; Procrit; Phoslo



Possible Omniscan side effects in 56 year old male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: 56 year old male

Reactions: Aphagia, Abasia, Skin Induration, Erythema, Walking AID User, Finger Deformity, Malaise, Joint Swelling, Skin Discolouration, Arthralgia, Oedema Peripheral, Pharyngitis Streptococcal, Urinary Retention, Infection

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Indication: Hepatic Cirrhosis

Omniscan
    Indication: Hepatic Cirrhosis

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2009-02-24
    End date: 2009-02-24

Omniscan
    Dosage: 20 mg, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2009-02-24
    End date: 2009-02-24

Other drugs received by patient: Sodium Chloride; Sodium Chloride



Possible Omniscan side effects in male

Reported by a lawyer from United States on 2012-04-19

Patient: male

Reactions: Femoral Arterial Stenosis, Headache, Cyst, Pulmonary Granuloma, Tunnel Vision, Malaise, Nodule, Actinic Keratosis, Back Pain, Prostate Cancer, Coronary Artery Disease, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Helicobacter Infection, Neurodermatitis, Stress, Activities of Daily Living Impaired, Ventricular Tachycardia, Ear Pain, Fall, Poor Quality Sleep, Fatigue, Basal Cell Carcinoma, Dizziness, Acute Myocardial Infarction, Squamous Cell Carcinoma, Nausea, Supraventricular Extrasystoles, Bundle Branch Block Left, Rash, Ascites, Carotid Artery Stenosis, Meniscus Lesion, Diarrhoea, Atrioventricular Block, Gait Disturbance, Asthenia, Arthritis, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-12-15
    End date: 2005-12-15

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-09-23

Other drugs received by patient: Minoxidil; Simvastatin; Diovan; Renal Softgel



Possible Omniscan side effects in female

Reported by a physician from Norway on 2012-04-04

Patient: female, weighing 40.0 kg (88.0 pounds)

Reactions: Pain in Extremity, Headache, Paraesthesia, Eye Pain, Haemoglobin Decreased, Visual Impairment, Dizziness, Serum Ferritin Decreased, Eyelid Ptosis, Skin Atrophy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan



Possible Omniscan side effects in male

Reported by a individual with unspecified qualification from Denmark on 2012-04-04

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Muscle Atrophy, Skin Exfoliation, Eczema, Joint Stiffness, Pruritus Generalised, Hypokinesia, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Fibrosis, Pain in Extremity, Skin Disorder, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Haemodialysis, Paraesthesia, Arthralgia, Grip Strength Decreased, Gait Disturbance

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan



Possible Omniscan side effects in male

Reported by a lawyer from United States on 2012-04-02

Patient: male

Reactions: Femoral Arterial Stenosis, Headache, Cyst, Pulmonary Granuloma, Tunnel Vision, Malaise, Nodule, Actinic Keratosis, Back Pain, Prostate Cancer, Coronary Artery Disease, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Helicobacter Infection, Neurodermatitis, Stress, Activities of Daily Living Impaired, Ventricular Tachycardia, Ear Pain, Fall, Poor Quality Sleep, Fatigue, Basal Cell Carcinoma, Dizziness, Acute Myocardial Infarction, Nausea, Squamous Cell Carcinoma, Supraventricular Extrasystoles, Bundle Branch Block Left, Rash, Ascites, Meniscus Lesion, Carotid Artery Stenosis, Diarrhoea, Atrioventricular Block, Gait Disturbance, Arthritis, Asthenia, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-09-23

Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-12-15
    End date: 2005-12-15

Other drugs received by patient: Renal Softgel; Diovan; Simvastatin; Minoxidil



Possible Omniscan side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-30

Patient: male, weighing 88.5 kg (194.6 pounds)

Reactions: Myalgia, Pain, Coma, Pyrexia, Unevaluable Event, Erythema

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 20.0 intravenous
    Indication: Imaging Procedure
    Start date: 2009-02-24

Sodium Chloride 0.9%
    Dosage: 40.0 ml intravenous
    Indication: Imaging Procedure
    Start date: 2009-02-24



Possible Omniscan side effects in male

Reported by a individual with unspecified qualification from Japan on 2012-03-29

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Nephrogenic Systemic Fibrosis, Skin Induration, Biopsy Skin Abnormal, Joint Stiffness, Joint Range of Motion Decreased, Skin Lesion, Swelling, Grip Strength Decreased, Gait Disturbance, Sclerema

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Indication: Hydrocephalus
    Start date: 2001-07-12
    End date: 2001-07-12

Omniscan
    Start date: 2001-08-08
    End date: 2001-08-08

Omniscan
    Indication: Acoustic Neuroma
    Start date: 2001-01-25
    End date: 2001-01-25

Omniscan
    Start date: 2005-02-25
    End date: 2005-02-25

Omniscan
    Dosage: 11.4 ml (0.2 ml/kg)
    Start date: 2003-04-02
    End date: 2003-04-02

Omniscan
    Dosage: 11.4 ml (0.2 ml/kg)
    Start date: 2003-11-19
    End date: 2003-11-19

Omniscan
    Dosage: 11.4 ml (0.2 ml/kg)
    Start date: 2004-11-17
    End date: 2004-11-17

Omniscan
    Dosage: 11.4 ml (0.2 ml/kg)
    Start date: 2004-05-19
    End date: 2004-05-19

Other drugs received by patient: Diltiazem Hydrochloride (Herbesser R); Marzulene-S (Levoglutamide W / Sodium Gualenate); Sodium Calcium; Lansoprazole; Ethyl Icosapenatate (Epadel S); Warfarin Sodium; Etizolam (Depas); Isosorbide Dinitrate (Frandol); Prohance



Possible Omniscan side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-03-29

Patient: female

Reactions: Joint Contracture, Talipes, Fibrosis, Nephrogenic Systemic Fibrosis, Scleroderma, Sclerema, Haemodialysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: less than 10 ml.
    Indication: Bladder Cancer
    Start date: 2002-12-28
    End date: 2002-12-28

Omniscan
    Indication: Renal Cancer Stage I
    Start date: 2006-05-27
    End date: 2006-05-27

Other drugs received by patient: Gadolinium Unspecified; Gadolinium Unspecified; Epogen; Pletal; Ferrous Citrate; Magnevist; Warfarin Sodium; Digoxin



Possible Omniscan side effects in male

Reported by a physician from Japan on 2012-03-28

Patient: male

Reactions: Morphoea, Joint Contracture, Pain, Joint Range of Motion Decreased, Skin Discolouration, Feeling Hot, Oedema Peripheral, Arteriovenous Fistula Site Complication, Pain in Extremity, Muscular Weakness, Skin Disorder, Calcinosis, Nephrogenic Systemic Fibrosis, Skin Induration, Gait Disturbance, Sclerema

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Omniscan
    Indication: Renal Transplant
    Start date: 2000-07-18
    End date: 2000-07-18

Omniscan
    Indication: Anastomotic Stenosis

Other drugs received by patient: Multiple Unspecified Drugs; Magnevist



Possible Omniscan side effects in female

Reported by a physician from Denmark on 2012-03-22

Patient: female, weighing 71.0 kg (156.2 pounds)

Reactions: Pruritus, Pain in Extremity, Musculoskeletal Pain, Nephrogenic Systemic Fibrosis, Skin Tightness, Myalgia, Arthralgia, Sensory Disturbance, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Start date: 2005-05-11
    End date: 2005-05-11

Omniscan
    Indication: Product Used FOR Unknown Indication
    Start date: 2004-10-22
    End date: 2004-10-22



Possible Omniscan side effects in 20 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21

Patient: 20 year old male, weighing 48.6 kg (106.9 pounds)

Reactions: Skin Exfoliation, Hypertrophy, Joint Contracture, Pain, Abasia, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Depression, Joint Effusion, Extremity Contracture, Pain in Extremity, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Tightness, Anxiety, Emotional Distress, Cachexia, Joint Warmth, Asthenia, Mobility Decreased

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-01-21
    End date: 2006-01-21

Omniscan
    Dosage: 30 ml, once
    Indication: Angiogram
    Start date: 2005-06-02
    End date: 2005-06-02

Omniscan

Other drugs received by patient: Enoxaparin; Labetalol HCL; Norvasc; Dantrolene Sodium; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Clonidine HCL; Darbepoetin Alfa; Hydralazine HCL; Fluoxetine; Cefazolin; Renagel; Coumadin



Possible Omniscan side effects in male

Reported by a physician from Denmark on 2012-03-14

Patient: male

Reactions: Back Pain, Pain in Extremity, Motor Dysfunction, Musculoskeletal Pain, Muscular Weakness, Nephrogenic Systemic Fibrosis, Poor Quality Sleep, Activities of Daily Living Impaired, Arthralgia, Gait Disturbance, Mobility Decreased, Decreased Appetite

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Start date: 2005-06-29
    End date: 2005-06-29

Omniscan
    Indication: Nephropathy
    Start date: 2003-01-13
    End date: 2005-06-29



Possible Omniscan side effects in female

Reported by a individual with unspecified qualification from Denmark on 2012-03-09

Patient: female, weighing 71.0 kg (156.2 pounds)

Reactions: Pruritus, Pain in Extremity, Musculoskeletal Pain, Nephrogenic Systemic Fibrosis, Skin Tightness, Myalgia, Arthralgia, Sensory Disturbance, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Indication: Product Used FOR Unknown Indication
    Start date: 2004-10-22
    End date: 2004-10-22

Omniscan
    Start date: 2005-05-11
    End date: 2005-05-11



Possible Omniscan side effects in male

Reported by a individual with unspecified qualification from Denmark on 2012-03-05

Patient: male, weighing 142.0 kg (312.4 pounds)

Reactions: Pruritus, Neuropathy Peripheral, Pain in Extremity, Activities of Daily Living Impaired, Joint Contracture, Skin Disorder, Nephrogenic Systemic Fibrosis, Peripheral Sensory Neuropathy

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Indication: Diagnostic Procedure

Omniscan
    Indication: Complications of Transplanted Kidney
    Start date: 2003-04-15
    End date: 2003-04-15



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012